Sevoflurane in COVID-19 ARDS (SevCov)

Clinical Trial ID NCT04355962

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04355962

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020 6.59
2 Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med 2020 0.97
3 The immunomodulatory effect of sevoflurane in endotoxin-injured alveolar epithelial cells. Anesth Analg 2007 0.97
4 Postconditioning with a volatile anaesthetic in alveolar epithelial cells in vitro. Eur Respir J 2007 0.91
Next 100